Tag: R&D

Research and development (R&D or R+D), also known in Europe as research and technical (or technological) development (RTD), is a general term for activities in connection with corporate or governmental innovation. Research and development is situated at the front end of the innovation life cycle, which may end with commercialization.

GC Pharma Established Cell Therapy Development Company

GC Pharma and affiliate GC LabCell said Thursday they have jointly established a cell therapy development company called Artiva Biotherapeutics. Artiva Biotherapeutics was launched in March in San ...

Bristol-Myers Announced New R&D Team

bristol-myers squibb
Bristol-Myers Squibb has unveiled the new-look team that will lead its R&D group after the closure of its Celgene takeover. The Big Pharma is dividing the group up into early- and late-phase d...

Top 15 Largest Pharma Companies Funneled more than $100b into R&D in 2018

Big Pharma companies are still, naturally, the big spenders in drug R&D, and the numbers are impressive: last year, and for the first time, the top 15 largest companies (by sales) funneled more th...

Pfizer Opened New R&D Facility in Missouri

Building on our 17-year history in Missouri, a newly opened, state-of-the-art, 295,000 square feet facility in Chesterfield will expand the capacity of colleagues dedicated to the research and develop...

Medicines Australia Welcomes R&D Tax Reform

lab
Medicines Australia welcomes announcement from the Australian Labor Party to reform the Research and Development (R&D) Tax Incentive if elected on 18 May. Medicines Australia CEO Ms Liz de Some...

Armenia Partners with WHISE-Embleema in Digital Healthcare

The Government of the Republic of Armenia, announced a partnership with the WHISE-Embleema Consortium, an organization whose mission is to accelerate the research and development of innovative new med...

Roche and Novartis are Among the Biggest Spenders on R&D in 2018

Over the past decade Roche and Novartis consistently spent more on R&D than other big pharma groups, evaluate.com reports. Abbvie and Astrazeneca have added to their budgets. The world’s 12 big...

Ono Pharmaceutical and twoXAR in R&D Collaboration

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced today that the c...

Servier and Oncodesign Team Up for R&D Parkinson’s Drug

Servier, an international pharmaceutical company governed by a non-profit foundation, and biopharmaceutical company, Oncodesign have announced a strategic partnership for the research and development ...

WuXi STA and Ark Biosciences Team Up for CMC Development

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Ark Biosciences, a global biotech company focusing on innovative drug discovery and development, especially in the area of ...

Abpro and NJCTTQ in Immuno-Oncology Collaboration

Collaboration to result in multiple new immuno-oncology bispecific therapeutic programs leveraging Abpro’s proprietary DiversImmuneTM antibody discovery platform for T-cell engagement. Abpro, a bio...

Morphic and Janssen in R&D Partnership

Morphic Therapeutic (Morphic), a biotechnology company developing oral integrin therapies, announced that it has entered into a research and development collaboration with Janssen Biotech, Inc. (Janss...

Abilita Bio and Amgen in Multi-Target Research Team

amgen
Abilita Bio, Inc. announced that it has entered into a multi-target research collaboration agreement with Amgen, a world leader in biotechnology. Under the terms of the agreement, Abilita Bio will lev...

Merck Expands US R&D Facility

Merck KGaA, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, is investing $70 million to expand its R&D facility in Billerica, MA. The new 145,000 sq.-ft. buildi...

SP Scientific Announced First New Advanced Freeze Dryers

The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation. SP Scientific has announced the...

Merck Expands R&D Facility

German drugs and Chemical group Merck KGaA announced a $70 million investment to expand its state of the art research and development (R&D) facility in Billerica, Massachusetts. The new buildin...